Follow-The-Filings

ENGN enGene Therapeutics

enGene Therapeutics earnings company data as of 6:22 AM ET 9/7

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Sep EPS
Rev

SEC filings

Recent issuer filings from EDGAR · 24 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01,9.01
8-K 7.01,9.01
8-K 5.02,7.01,9.01
8-K/A 2.05,5.02
8-K 2.02,2.05,5.02,7.01,8.01,9.01
10-Q
8-K 5.07,9.01
8-K 5.02,7.01,8.01,9.01
8-K 5.03,7.01,9.01
8-K 2.02,9.01
10-Q
8-K 1.01,1.02,9.01
424B5
10-K/A
8-K 7.01,9.01
8-K 1.01,2.03,3.02,9.01
8-K 2.02,9.01
10-K
424B5
8-K 1.01,7.01,9.01
8-K 7.01,8.01,9.01
424B5
8-K/A 5.02
8-K 5.02

Insider forms

Form 3 / 4 / 5 from EDGAR · 1 row shown

Filed Form Detail Links
4 Period Jun 16, 2026 · 5 forms

11 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice